Drug Profile


Alternative Names: ADD 75073; LY 201116

Latest Information Update: 28 Jan 1997

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Research Corporation Technologies
  • Developer Eli Lilly; Research Corporation Technologies
  • Class Antiarrhythmics; Antiepileptic drugs; Benzamides; Neuroprotectants; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Epilepsy

Most Recent Events

  • 24 Jan 1997 New profile
  • 24 Jan 1997 Discontinued-I for Epilepsy in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top